Wells Fargo Upgrades Q32 Bio to Overweight, Announces $66 Price Target
Benzinga Newsdesk 3 months ago
NewsUpgradesAnalyst RatingsPrice Target
Wells Fargo analyst Derek Archila upgrades Q32 Bio (NASDAQ:QTTB) from Equal-Weight to Overweight and announces $66 price target.
Wells Fargo analyst Derek Archila upgrades Q32 Bio (NASDAQ:QTTB) from Equal-Weight to Overweight and announces $66 price target.